Literature DB >> 7430342

Synthesis and secretion of cystic fibrosis ciliary dyskinesia substances by purified subpopulations of leukocytes.

G B Wilson, V J Bahm.   

Abstract

Cultured peripheral blood leukocytes (PBL) from individuals homozygous or heterozygous for the defective gene causing the inherited disease cystic fibrosis (CF) secrete three different ciliary dyskinesia substances (CDS), which can be detected by their activity in vitro in a rabbit mucociliary bioassay. Their PBL also release substances that promote mucus expulsion and destruction of the ciliated epithelium. In the present study the relative numbers of lymphocytes (T, B, and null), monocytes-macrophages (Mphi), and polymorphonuclear neutrophils were found to be normal in subjects with the CF gene, as were the responses of their PBL to phytohemagglutinin and pokeweed mitogen. Using purified subpopulations of leukocytes, we obtained evidence that both monocytes and T lymphocytes can secrete CDS in vitro with no requirement for cooperation with other lymphocyte subsets, whereas B and "null" lymphocytes probably require either differentiation or cellular cooperation for optimal secretion of CDS. Mucus expulsion and tissue destruction were produced by substances released primarily from polymorphonuclear neutrophils and secondarily from Mphi. Using cycloheximide and actinomycin D, we obtained evidence that CDS accumulation requires active protein synthesis and is not dependent on newly synthesized RNA, at least in short-term cultures. Gel filtration chromatography of active culture supernates showed that T lymphocytes synthesized only a CF-specific CDS, whereas Mphi synthesized all three CDS found in PBL cultures. Evidence is presented that one CDS is related structurally to C3a, since it can be removed with rabbit antisera specific for human C3a.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7430342      PMCID: PMC371538          DOI: 10.1172/JCI109929

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Lymphocyte activation. V. Quantitation of the proliferative responses to mitogens using defined T and B cell populations.

Authors:  G Janossy; M F Greaves; M J Doenhoff; J Snajdr
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

2.  Studies on ciliary dyskinesia factor in cystic fibrosis. II. Short term leukocyte cultures and long term lymphoid lines.

Authors:  J H Conover; N G Beratis; E J Conod; E Ainbender; K Hirschhorn
Journal:  Pediatr Res       Date:  1973-04       Impact factor: 3.756

3.  Studies on ciliary dyskinesia factor in cystic fibrosis. 3. Skin fibroblasts and cultured amniotic fluid cells.

Authors:  N G Beratis; J H Conover; E J Conod; R J Bonforte; K Hirschhorn
Journal:  Pediatr Res       Date:  1973-12       Impact factor: 3.756

4.  Abnormal beta-glucuronidase activity in cystic fibrosis.

Authors:  A G Marchi; M A Marchi; G Mastella; S Nordio
Journal:  Helv Paediatr Acta       Date:  1973-11

5.  Products of lymphoid cells in continuous culture.

Authors:  P R Glade; K Hirschhorn
Journal:  Am J Pathol       Date:  1970-09       Impact factor: 4.307

6.  Cystic fibrosis: fractionation of fibroblast media demonstrating ciliary inhibition.

Authors:  B H Bowman; D R Barnett; R Matalon; B S Danes; A G Bearn
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

7.  Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes.

Authors:  G D Ross; E M Rabellino; M J Polley; H M Grey
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

8.  The isolation and selected properties of blood monocytes.

Authors:  W E Bennett; Z A Cohn
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

9.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

10.  A plasmin-split fragment of C'3 as a new chemotactic factor.

Authors:  P A Ward
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Clinical Phenotypes of Cystic Fibrosis Carriers.

Authors:  Philip M Polgreen; Alejandro P Comellas
Journal:  Annu Rev Med       Date:  2022-01-27       Impact factor: 13.739

2.  Cystic fibrosis ciliary dyskinesia substances and pulmonary disease. Effects of ciliary dyskinesia substances on neutrophil movement in vitro.

Authors:  G B Wilson; H H Fudenberg; M T Parise; E Floyd
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

Review 3.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 4.  Cystic Fibrosis Lung Immunity: The Role of the Macrophage.

Authors:  Emanuela M Bruscia; Tracey L Bonfield
Journal:  J Innate Immun       Date:  2016-06-24       Impact factor: 7.349

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.